GWM
OLMA icon

Greenline Wealth Management’s Olema Pharmaceuticals OLMA Stock Holding History

Greenline Wealth Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-111
Closed -$2.77K – 372
2025
Q4 		$2.77K Buy
+111
New +$1.98K ﹤0.01% 442

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Greenline Wealth Management's OLMA Position: Q1 2026 in Review

Greenline Wealth Management sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 111 shares — an estimated $2.77K sold.

Greenline Wealth Management first reported a position in OLMA in Q4 2025 and held it in 1 quarter. The position peaked at $2.77K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Greenline Wealth Management reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Greenline Wealth Management sold 111 Olema Pharmaceuticals shares in Q1 2026, an estimated $2.77K.
  • Greenline Wealth Management first reported a position in Olema Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Greenline Wealth Management's Olema Pharmaceuticals position peaked at $2.77K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Greenline Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.